![]() |
Volumn 8, Issue 8, 2006, Pages
|
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ATORVASTATIN;
CALCIUM CHANNEL BLOCKING AGENT;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PYRROLE DERIVATIVE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
DRUG EFFECT;
DYSLIPIDEMIA;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERTENSION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AMLODIPINE;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
CHOLESTEROL, LDL;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
DYSLIPIDEMIAS;
FEMALE;
FOLLOW-UP STUDIES;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERTENSION;
MALE;
MIDDLE AGED;
PYRROLES;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 33750950650
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2006.05636.x Document Type: Article |
Times cited : (54)
|
References (0)
|